January 15, 2018/by Philip RyeAlgiPharma’s Cystic Fibrosis drug candidate OligoG awarded pivotal trial grant of €6 million from EU’s Horizon 2020 programme
January 15, 2018/by Philip RyeAlgiPharma receives up to an additional $3 million from the US Cystic Fibrosis Foundation (CFF)
January 15, 2018/by Philip RyeAlgiPharma awarded 4 year grant from the Norwegian Research Council’s NANO2021 programme
